Qualcomm brings wireless data capture to Johnson & Johnson glucose meters

handshake
Qualcomm and LifeScan's agreement will facilitate physician access to glucose meter data.

Qualcomm and Johnson & Johnson’s LifeScan unit have teamed up to enable wireless data collection for one of the latter’s blood glucose meters.

Under the agreement, Qualcomm Life’s 2net solution will allow cable-free data capture for physicians caring for patients using LifeScan’s OneTouch Verio Flex blood glucose meters

Patients may easily sync their glucose data via Bluetooth to the accompanying OneTouch Reveal mobile app, but physicians trying to access this data have a harder time. They have to do so manually, in a process that requires “multiple cables and software versions,” Qualcomm said in a statement.

Whitepaper

Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Qualcomm’s 2net platform allows the Verio Flex meter to send data to the cloud, so that physicians may access a patient’s historical and recent blood glucose data on which to base care decisions, according to the statement.

"Enabling timely access to blood glucose data generates actionable insights for physicians and patients for more informed diabetes care management," said Rick Valencia, president of Qualcomm’s Qualcomm Life subsidiary, in the statement. "The secure, wireless data capture that 2net provides is valuable for clinicians as they seek transformative ways to treat people with diabetes efficiently and effectively across the care continuum."

RELATED: Philips, Qualcomm partner on personalized, connected health

The duo plans a limited rollout of the 2net solution to physicians’ offices this fall, and to introduce it globally in 2018.

This isn’t Qualcomm’s first partnership with a major diabetes device maker—in May last year, the company joined forces with Medtronic to create an affordable, wireless, disposable continuous glucose monitor.

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy.